N-[(1S)-5-amino-1-cyano-pentyl]-2-[(1R)-1-[2,5-dioxo-3-(4-phenoxyphenyl)imidazolidin-1-yl]-2-methyl-propyl]-3-methyl-benzimidazole-5-carboxamide

ID: ALA3799985

Chembl Id: CHEMBL3799985

PubChem CID: 127045987

Max Phase: Preclinical

Molecular Formula: C34H37N7O4

Molecular Weight: 607.71

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)[C@H](c1nc2ccc(C(=O)N[C@H](C#N)CCCCN)cc2n1C)N1C(=O)CN(c2ccc(Oc3ccccc3)cc2)C1=O

Standard InChI:  InChI=1S/C34H37N7O4/c1-22(2)31(32-38-28-17-12-23(19-29(28)39(32)3)33(43)37-24(20-36)9-7-8-18-35)41-30(42)21-40(34(41)44)25-13-15-27(16-14-25)45-26-10-5-4-6-11-26/h4-6,10-17,19,22,24,31H,7-9,18,21,35H2,1-3H3,(H,37,43)/t24-,31+/m0/s1

Standard InChI Key:  DSDWJRWQTOQHQZ-QXNWPYRLSA-N

Alternative Forms

  1. Parent:

    ALA3799985

    ---

Associated Targets(Human)

PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 607.71Molecular Weight (Monoisotopic): 607.2907AlogP: 5.28#Rotatable Bonds: 12
Polar Surface Area: 146.58Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.33CX Basic pKa: 10.20CX LogP: 3.97CX LogD: 1.36
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.16Np Likeness Score: -0.94

References

1. Teno N, Gohda K, Yamashita Y, Otsubo T, Yamaguchi M, Wanaka K, Tsuda Y..  (2016)  Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity.,  26  (9): [PMID:27009905] [10.1016/j.bmcl.2016.03.047]

Source